112 results on '"Borowitz, Drucy"'
Search Results
2. Peer Review Report For: A grumbling concern: A survey of gastrointestinal symptoms in cystic fibrosis in the modulator era [version 2; peer review: 2 approved, 3 approved with reservations]
3. Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force
4. Peer Review Report For: A randomised crossover trial of tezacaftor-ivacaftor for gut dysfunction in cystic fibrosis with magnetic resonance imaging (MRI) outcomes. [version 1; peer review: 1 approved, 1 approved with reservations]
5. Incidence of fibrosing colonopathy with pancreatic enzyme replacement therapy in patients with cystic fibrosis
6. Upper airway microbiota development in infants with cystic fibrosis diagnosed by newborn screen
7. Airway clearance after highly effective CFTR modulators: Normalizing life and reducing treatment burden
8. Validation of an omega-3 substrate challenge absorption test as an indicator of global fat lipolysis
9. Autoimmunity in people with cystic fibrosis
10. Airway Clearance after Highly Effective CFTR Modulators: Normalizing Life and Reducing Treatment Burden
11. Impaired distal colonic pH in adults with cystic fibrosis
12. Lessons learned about publication of results of community surveys when regulatory oversight has not occurred
13. Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis
14. Community Perspective on Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis
15. Association between stool consistency and clinical variables among infants with cystic fibrosis: Findings from the BONUS study
16. Changes in Glucose Breath Test in Cystic Fibrosis Patients Treated with one Month of Lumacaftor/ivacaftor
17. Coefficient of Fat Absorption to Measure the Efficacy of Pancreatic Enzyme Replacement Therapy in People With Cystic Fibrosis
18. Review of Gastrointestinal Motility in Cystic Fibrosis
19. Designing the GALAXY study: Partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms
20. DIGEST: Developing innovative gastroenterology specialty training
21. Gastrointestinal Factors Associated With Hospitalization in Infants With Cystic Fibrosis: Results From the Baby Observational and Nutrition Study
22. Systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic
23. Clinical Effectiveness of Lumacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for F508del-CFTR. A Clinical Trial
24. Virtual Peer Support for People With Cystic Fibrosis and Their Family Members: A Program Evaluation
25. Oral Glutathione and Growth in Cystic Fibrosis: A Multicenter, Randomized, Placebo-controlled, Double-blind Trial
26. Creating a Virtual Environment to Enable Two-Way Learning about the Relevance of Clinical Research
27. Hemoptysis from the perspective of people with cystic fibrosis
28. Challenging barriers to an option for improved provision of enteral nutrition
29. RNA sequencing data from neutrophils of patients with cystic fibrosis reveals potential for developing biomarkers for pulmonary exacerbations
30. Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study
31. CFTR modulator theratyping: Current status, gaps and future directions
32. Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis—Knowledge Gaps and Research Opportunities
33. Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial
34. Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening
35. Difficult conversations: Discussing prognosis with children with cystic fibrosis
36. Reduction of Recurrence Risk of Pancreatitis in Cystic Fibrosis With Ivacaftor
37. Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation
38. Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome and Cystic Fibrosis Screen Positive, Inconclusive Diagnosis
39. Cystic Fibrosis
40. Cystic Fibrosis
41. Difficult Conversations: Discussing Prognosis with Children with Cystic Fibrosis (FR481A)
42. Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function
43. CFTR, bicarbonate, and the pathophysiology of cystic fibrosis
44. Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor
45. Equivalent substrates enable simultaneous study of gastrointestinal pH and CF-related diabetes
46. Standardization of Research-Quality Anthropometric Measurement of Infants and Implementation in a Multicenter Study
47. Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation
48. Early attained weight and length predict growth faltering better than velocity measures in infants with CF
49. Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)
50. Starting an Academic Career and Starting a Family: Challenges and Some Potential Solutions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.